This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
7o4d
From Proteopedia
(Difference between revisions)
m (Protected "7o4d" [edit=sysop:move=sysop]) |
|||
| Line 1: | Line 1: | ||
| - | '''Unreleased structure''' | ||
| - | + | ==QR2 inhibitor from a novel sulfanamide series to tackle age related oxidative stress and cognitive decline== | |
| - | + | <StructureSection load='7o4d' size='340' side='right'caption='[[7o4d]]' scene=''> | |
| - | + | == Structural highlights == | |
| - | + | <table><tr><td colspan='2'>Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=7O4D OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=7O4D FirstGlance]. <br> | |
| - | + | </td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=7o4d FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=7o4d OCA], [https://pdbe.org/7o4d PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=7o4d RCSB], [https://www.ebi.ac.uk/pdbsum/7o4d PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=7o4d ProSAT]</span></td></tr> | |
| - | [[Category: | + | </table> |
| - | [[Category: | + | __TOC__ |
| - | [[Category: | + | </StructureSection> |
| - | [[Category: | + | [[Category: Large Structures]] |
| - | [[Category: | + | [[Category: Albeck S]] |
| - | [[Category: | + | [[Category: Babaev I]] |
| - | [[Category: | + | [[Category: Barr H]] |
| - | [[Category: | + | [[Category: Carvalh S]] |
| - | [[Category: | + | [[Category: David O]] |
| - | [[Category: | + | [[Category: Dym O]] |
| - | [[Category: | + | [[Category: Edry E]] |
| - | [[Category: | + | [[Category: Elkobi A]] |
| - | [[Category: | + | [[Category: Germain N]] |
| - | [[Category: | + | [[Category: Gould NL]] |
| - | [[Category: | + | [[Category: Lefker B]] |
| - | [[Category: | + | [[Category: Peleg Y]] |
| - | [[Category: | + | [[Category: Rosenblum K]] |
| - | [[Category: | + | [[Category: Scherer GR]] |
| + | [[Category: Sharir H]] | ||
| + | [[Category: Shurrush K]] | ||
| + | [[Category: Subramanyam C]] | ||
Revision as of 06:15, 18 August 2022
QR2 inhibitor from a novel sulfanamide series to tackle age related oxidative stress and cognitive decline
| |||||||||||
Categories: Large Structures | Albeck S | Babaev I | Barr H | Carvalh S | David O | Dym O | Edry E | Elkobi A | Germain N | Gould NL | Lefker B | Peleg Y | Rosenblum K | Scherer GR | Sharir H | Shurrush K | Subramanyam C
